跳至主要内容
临床试验/ISRCTN67540073
ISRCTN67540073已完成未知

A multi-centre, randomised, double blind, placebo-controlled trial evaluating the effects of early administration of fibrinogen concentrate in adults with major traumatic haemorrhage.

HS Blood and Transplant (NHSBT)0 个研究点目标入组 48 人开始时间: 2015年8月6日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
48

研究概览

简要总结

2018 Results article in https://www.ncbi.nlm.nih.gov/pubmed/29914530 results 2017 Protocol article in https://doi.org/10.1186/s13063-017-1980-x (added 12/09/2023)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Written informed consent or agreement, or waiver of consent, is obtained before any study related activity
  • 2. The participant is judged to be an adult (aged 16 years or over) and is affected by traumatic injury
  • 3. The participant is deemed by the attending clinician to have ongoing active haemorrhage with shock
  • AND REQUIRES:
  • 4. Activation of the local major haemorrhage protocol for management of severe blood loss and/or transfusion of emergency (Group O) red cells

排除标准

  • 1. The participant has been transferred from another hospital
  • 2. The trauma team leader deems the patient inappropriate for the trial i.e. injuries deemed to be incompatible with life
  • 3. More than 3 hours have elapsed from the time of injury
  • 4. The participant is pregnant
  • 5. Severe isolated TBI or unsalvageable head injury

研究者

发起方
HS Blood and Transplant (NHSBT)

相似试验